Labcorp (LH) Competitors $261.36 -0.52 (-0.20%) Closing price 07/29/2025 03:59 PM EasternExtended Trading$264.10 +2.73 (+1.05%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LH vs. HOLX, HSIC, MEDP, AMN, CAH, CHE, DGX, MCK, TMO, and WSTShould you be buying Labcorp stock or one of its competitors? The main competitors of Labcorp include Hologic (HOLX), Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Cardinal Health (CAH), Chemed (CHE), Quest Diagnostics (DGX), McKesson (MCK), Thermo Fisher Scientific (TMO), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Labcorp vs. Its Competitors Hologic Henry Schein Medpace AMN Healthcare Services Cardinal Health Chemed Quest Diagnostics McKesson Thermo Fisher Scientific West Pharmaceutical Services Labcorp (NYSE:LH) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment. Which has better earnings and valuation, LH or HOLX? Hologic has lower revenue, but higher earnings than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.68$746M$9.0628.85Hologic$4.03B3.65$789.50M$2.3727.86 Does the media prefer LH or HOLX? In the previous week, Labcorp had 34 more articles in the media than Hologic. MarketBeat recorded 54 mentions for Labcorp and 20 mentions for Hologic. Hologic's average media sentiment score of 1.33 beat Labcorp's score of 0.96 indicating that Hologic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 23 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 14 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate LH or HOLX? Labcorp presently has a consensus price target of $285.00, indicating a potential upside of 9.04%. Hologic has a consensus price target of $77.33, indicating a potential upside of 17.10%. Given Hologic's higher probable upside, analysts plainly believe Hologic is more favorable than Labcorp.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.57Hologic 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.47 Is LH or HOLX more profitable? Hologic has a net margin of 13.83% compared to Labcorp's net margin of 5.66%. Hologic's return on equity of 19.71% beat Labcorp's return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% Hologic 13.83%19.71%10.87% Which has more risk and volatility, LH or HOLX? Labcorp has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Do insiders and institutionals believe in LH or HOLX? 95.9% of Labcorp shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryHologic beats Labcorp on 9 of the 17 factors compared between the two stocks. Get Labcorp News Delivered to You Automatically Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LH vs. The Competition Export to ExcelMetricLabcorpMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$21.92B$7.31B$5.70B$21.03BDividend Yield1.10%2.81%4.71%3.60%P/E Ratio28.8524.5928.1927.92Price / Sales1.6834.83391.9468.05Price / Cash11.6926.9436.3223.29Price / Book2.588.858.284.54Net Income$746M$239.96M$3.25B$993.24M7 Day Performance4.13%-4.69%-2.00%-1.51%1 Month Performance-0.39%0.86%8.67%3.16%1 Year Performance22.67%10.27%34.65%9.14% Labcorp Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LHLabcorp4.2323 of 5 stars$261.36-0.2%$285.00+9.0%+24.0%$21.92B$13.01B28.8570,000Earnings ReportInsider TradeAnalyst RevisionHOLXHologic4.8073 of 5 stars$63.69-0.5%$77.33+21.4%-17.1%$14.19B$4.03B26.877,063Positive NewsHSICHenry Schein4.2703 of 5 stars$69.070.0%$78.36+13.5%-2.0%$8.41B$12.67B21.5825,000Upcoming EarningsMEDPMedpace3.8283 of 5 stars$308.88-1.0%$344.82+11.6%+16.3%$8.88B$2.11B23.585,900Trending NewsAnalyst ForecastInsider TradeHigh Trading VolumeAMNAMN Healthcare Services4.3899 of 5 stars$18.52-6.6%$32.08+73.3%-70.0%$708.83M$2.98B-4.282,968Positive NewsCAHCardinal Health4.8751 of 5 stars$158.66-0.6%$158.07-0.4%+60.2%$37.87B$222.29B24.7548,900Positive NewsCHEChemed4.9858 of 5 stars$450.09-0.3%$645.00+43.3%-15.8%$6.58B$2.43B21.9215,695DGXQuest Diagnostics4.9438 of 5 stars$166.93+0.0%$186.07+11.5%+18.1%$18.64B$9.87B21.1056,000MCKMcKesson4.3561 of 5 stars$711.19+0.2%$710.17-0.1%+17.4%$88.98B$359.05B27.5345,000Positive NewsUpcoming EarningsTMOThermo Fisher Scientific4.9461 of 5 stars$405.15-2.3%$599.30+47.9%-20.1%$152.94B$42.88B23.76125,000Trending NewsEarnings ReportInsider TradeAnalyst RevisionWSTWest Pharmaceutical Services4.7675 of 5 stars$210.56-0.2%$320.00+52.0%-12.3%$15.13B$2.89B33.0510,600Trending NewsEarnings ReportDividend IncreaseAnalyst Revision Related Companies and Tools Related Companies HOLX Alternatives HSIC Alternatives MEDP Alternatives AMN Alternatives CAH Alternatives CHE Alternatives DGX Alternatives MCK Alternatives TMO Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LH) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...American Alternative | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Labcorp Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Labcorp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
